-+ 0.00%
-+ 0.00%
-+ 0.00%

EVOGENE ANNOUNCES ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) AS THE TARGET INDICATION FOR ITS INTERNAL AI-DRIVEN DRUG DISCOVERY PROGRAM

Reuters·10/28/2026 12:32:44